312 related articles for article (PubMed ID: 27908528)
1. Prognostic significance of lymphadenectomy and prevalence of lymph node metastasis in clinically-apparent stage I endometrioid and mucinous ovarian carcinoma.
Nasioudis D; Chapman-Davis E; Witkin SS; Holcomb K
Gynecol Oncol; 2017 Feb; 144(2):414-419. PubMed ID: 27908528
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of lymph node metastasis and prognostic significance of lymphadenectomy in apparent early-stage malignant ovarian sex cord-stromal tumors.
Nasioudis D; Kanninen TT; Holcomb K; Sisti G; Witkin SS
Gynecol Oncol; 2017 May; 145(2):243-247. PubMed ID: 28292524
[TBL] [Abstract][Full Text] [Related]
3. Does tumor grade influence the rate of lymph node metastasis in apparent early stage ovarian cancer?
Nasioudis D; Mastroyannis SA; Ko EM; Latif NA
Arch Gynecol Obstet; 2018 Jul; 298(1):179-182. PubMed ID: 29785550
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and prognostic impact of lymphadenectomy and lymph node metastasis in clinically early-stage ovarian clear cell carcinoma.
Mahdi H; Moslemi-Kebria M; Levinson KL; Gojayev A; Lockhart D; Ali-Fehmi R; Munkarah AR
Int J Gynecol Cancer; 2013 Sep; 23(7):1226-30. PubMed ID: 23736258
[TBL] [Abstract][Full Text] [Related]
5. Mucinous Adenocarcinoma of the Endometrium Compared With Endometrioid Endometrial Cancer: A SEER Analysis.
Rauh-Hain JA; Vargas RJ; Clemmer J; Clark RM; Bradford LS; Growdon WB; Goodman A; Boruta DM; Schorge JO; del Carmen MG
Am J Clin Oncol; 2016 Feb; 39(1):43-8. PubMed ID: 24390270
[TBL] [Abstract][Full Text] [Related]
6. Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study.
Sieh W; Köbel M; Longacre TA; Bowtell DD; deFazio A; Goodman MT; Høgdall E; Deen S; Wentzensen N; Moysich KB; Brenton JD; Clarke BA; Menon U; Gilks CB; Kim A; Madore J; Fereday S; George J; Galletta L; Lurie G; Wilkens LR; Carney ME; Thompson PJ; Matsuno RK; Kjær SK; Jensen A; Høgdall C; Kalli KR; Fridley BL; Keeney GL; Vierkant RA; Cunningham JM; Brinton LA; Yang HP; Sherman ME; García-Closas M; Lissowska J; Odunsi K; Morrison C; Lele S; Bshara W; Sucheston L; Jimenez-Linan M; Driver K; Alsop J; Mack M; McGuire V; Rothstein JH; Rosen BP; Bernardini MQ; Mackay H; Oza A; Wozniak EL; Benjamin E; Gentry-Maharaj A; Gayther SA; Tinker AV; Prentice LM; Chow C; Anglesio MS; Johnatty SE; Chenevix-Trench G; Whittemore AS; Pharoah PD; Goode EL; Huntsman DG; Ramus SJ
Lancet Oncol; 2013 Aug; 14(9):853-62. PubMed ID: 23845225
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of sentinel lymph node mapping for patients with FIGO stage I endometrioid endometrial carcinoma.
Nasioudis D; Byrne M; Ko EM; Giuntoli RL; Haggerty AF; Cory L; Kim SH; Morgan MA; Latif NA
Gynecol Oncol; 2021 Jun; 161(3):705-709. PubMed ID: 33771397
[TBL] [Abstract][Full Text] [Related]
8. The prognostic significance of aortic lymph node metastasis in endometrial cancer: Potential implications for selective aortic lymph node assessment.
Cosgrove CM; Cohn DE; Rhoades J; Felix AS
Gynecol Oncol; 2019 Jun; 153(3):505-510. PubMed ID: 30935714
[TBL] [Abstract][Full Text] [Related]
9. Extent of lymph node dissection and overall survival in patients with uterine carcinosarcoma, papillary serous and endometrioid adenocarcinoma: A retrospective cohort study.
Alagkiozidis I; Weedon J; Grossman A; Wang P; Mize B; Wilson K; Shah T; Economos K; Salame G; Abulafia O; Lee YC
Int J Surg; 2015 Dec; 24(Pt A):9-13. PubMed ID: 26476418
[TBL] [Abstract][Full Text] [Related]
10. Lymphadenectomy and prognosis for elderly females with stage I endometrioid endometrial cancer.
Zhao L; Li L; Ye Y; Han X; Fu X; Yu Y; Luo J
Arch Gynecol Obstet; 2019 Sep; 300(3):683-691. PubMed ID: 31256231
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of lymph node metastasis and clear cell histology in ovarian carcinoma limited to the pelvis (pT1M0 and pT2M0).
Sakuragi N; Yamada H; Oikawa M; Okuyama K; Fujino T; Sagawa T; Fujimoto S
Gynecol Oncol; 2000 Nov; 79(2):251-5. PubMed ID: 11063653
[TBL] [Abstract][Full Text] [Related]
12. Impact on survival with adjuvant radiotherapy for clear cell, mucinous, and endometriod ovarian cancer: the SEER experience from 2004 to 2011.
Patel SC; Frandsen J; Bhatia S; Gaffney D
J Gynecol Oncol; 2016 Sep; 27(5):e45. PubMed ID: 27329193
[TBL] [Abstract][Full Text] [Related]
13. Malignant and borderline epithelial ovarian tumors in the pediatric and adolescent population.
Nasioudis D; Alevizakos M; Holcomb K; Witkin SS
Maturitas; 2017 Feb; 96():45-50. PubMed ID: 28041594
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of mucinous differentiation of endometrioid adenocarcinoma of the endometrium.
Galic V; Schiavone MB; Herzog TJ; Holcomb K; Lewin SN; Lu YS; Neugut AI; Hershman DL; Wright JD
Cancer Invest; 2013 Aug; 31(7):500-4. PubMed ID: 23915075
[TBL] [Abstract][Full Text] [Related]
15. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
Ma SK; Zhang HT; Sun YC; Wu LY
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
[TBL] [Abstract][Full Text] [Related]
16. Surgical lymph node assessment in mucinous ovarian carcinoma staging: a systematic review and meta-analysis.
Hoogendam JP; Vlek CA; Witteveen PO; Verheijen R; Zweemer RP
BJOG; 2017 Feb; 124(3):370-378. PubMed ID: 27444115
[TBL] [Abstract][Full Text] [Related]
17. Mucinous borderline ovarian tumor versus invasive well-differentiated mucinous ovarian cancer: Difference in characteristics and outcomes.
Matsuo K; Machida H; Mandelbaum RS; Grubbs BH; Roman LD; Sood AK; Gershenson DM
Gynecol Oncol; 2019 May; 153(2):230-237. PubMed ID: 30797590
[TBL] [Abstract][Full Text] [Related]
18. Endometrioid Carcinoma of the Ovary: Outcomes Compared to Serous Carcinoma After 10 Years of Follow-Up.
Bouchard-Fortier G; Panzarella T; Rosen B; Chapman W; Gien LT
J Obstet Gynaecol Can; 2017 Jan; 39(1):34-41. PubMed ID: 28062021
[TBL] [Abstract][Full Text] [Related]
19. Impact of lymphadenectomy in uterine endometrioid carcinoma.
Huang CY; Ho CM; Chen YL; You SL; Chen CA; Cheng WF
Eur J Surg Oncol; 2013 Apr; 39(4):350-7. PubMed ID: 23462243
[TBL] [Abstract][Full Text] [Related]
20. [Effect of retroperitoneal lymphadenectomy on survival of patients with epithelial ovarian cancer].
Xiong ZF; Wang ZH; Wang SX
Zhonghua Fu Chan Ke Za Zhi; 2003 Feb; 38(2):77-80. PubMed ID: 12783692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
